Pharmacists and Pharmacy Techs: New CE Requirements. Click here for more info.

- Multimedia -

Needle-Free Connectors

Critical Research Results: Can We Predict Infection Risk?

Activity Description

The risk of bloodstream infection associated with the use of needle-free connectors for central line access is an important issue in nursing care. A broad classification system has been proposed as a guide to infection risk. But does it differentiate the critical design features that may play a role in risk reduction? The newly revised CDC guideline for prevention of catheter-related bloodstream infections (CRBSI) states: "When needleless systems are used, a split septum valve may be preferred over a mechanical valve due to increased risk of infection with some mechanical valves." Many questions remain regarding the risk of CRBSI with various connectors. This webinar series will enhance the clinician's understanding of device classification and will examine recent data that give new perspective on risk factors associated with the use of needle-free connectors.

Learning Objectives

Upon completion of this activity, nurses will be able to:

  • Identify the critical factors associated with infection risks and the use of needle-free connectors

  • Compare and contrast research results on bacterial transfer and the risk of CRBSI associated with different needle-free devices

  • Establish strategies for minimizing the risk of CRBSI

Faculty

Marcia Ryder, PhD, MS, RN
Ryder Science
Medical Biofilm Research
San Marcos, California

Disclosure

It is the policy of ProCE, Inc. to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Dr. Ryder has disclosed the following financial and/or commercial relationships: Speaker/Consultant: Agion, Inc., Bard Vascular Access, Baxter Healthcare, Inc., CareFusion, Inc., Excelsior Medical, Inc., ICU Medical, Inc., Johnson & Johnson, Novabay, Inc., PFM Medical, Inc., Sage Products, Inc., Teleflex Medical, Inc., 3M; Research Grants: HRSA, Sigma Theta Tau (SF chapter). The planners of this activity have no real or perceived financial relationships to disclose.
 
Please note: The information and views presented in this CE activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications. Use of drugs and/or devices outside of labeling should be considered experimental. Participants are advised to consult and verify manufacturer product information, the professional literature and use his/her professional judgment in applying the presented information in patient care activities.

CE Accreditation

Release Date: 01-21-2011

Expiration Date: 01-21-2014

Nurses
CE is provided for this activity through collaboration between ProCE, Inc. and Wild Iris Medical Education, Inc. Wild Iris Medical Education, Inc. is accredited as a provider of continuing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 1.0 contact hour of nurse CE credit.

Funding

This activity was supported by an unrestricted educational grant from ICU Medical, Inc., and Hospira, Inc.




To Participate

To participate in this Web-based continuing education activity:

1. Review the activity description and objectives.
2. View the activity by clicking on the link below.
3. Take the online post-test and complete the evaluation by clicking the post-test hyperlink on the final slide of the activity (registration will be required).
View this Activity
View as Flash
Download Handouts
Post-Test / Evaluation and CE Statement

To take the post-test, complete the evaluation, and to obtain your CE/CME statement:

  • New User
    Click here to register
  • Existing User / Not Yet Enrolled in this Course
    Click here to enroll
    (previous ProCE user that has NOT yet enrolled in this specific course)
  • Existing User / Already Enrolled in the Course
    Click here
    (To resume taking the post-test OR Reprint CE Statement)

NOTE: If you attended the webinar titled "Needle-Free Connectors: Critical Research Results: Can We Predict Infection Risk?" that was held on January 6 & 11, 2011 AND received CE credit (i.e. a nurse CE certificate), you are NOT allowed to receive credit again for this home-study web course.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Click here for ProCE, Inc.'s Privacy Policy.

Copyright © 2002-2012 - ProCE, Inc. - All Rights Reserved
Web Address www.ProCE.com • E-Mail Info@ProCE.com
Phone 630.540.2848 • Fax 630.540.2849